WO2012093524A1 - 水中油型乳化組成物 - Google Patents
水中油型乳化組成物 Download PDFInfo
- Publication number
- WO2012093524A1 WO2012093524A1 PCT/JP2011/076994 JP2011076994W WO2012093524A1 WO 2012093524 A1 WO2012093524 A1 WO 2012093524A1 JP 2011076994 W JP2011076994 W JP 2011076994W WO 2012093524 A1 WO2012093524 A1 WO 2012093524A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oil
- water emulsion
- emulsion composition
- component
- mass
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Definitions
- the present invention relates to an oil-in-water emulsified composition excellent in feel.
- an oil-in-water emulsion composition has been used as a sunscreen because of its good feel when applied to the skin compared to a water-in-oil emulsion composition.
- ultraviolet absorbers used for sunscreens have poor solubility in solvents and are insoluble in humectants such as glycerin and water, so that it is difficult to stably add them to an oil-in-water emulsion composition. Therefore, an oil-in-water emulsion preparation using a surfactant having an alkylene oxide group that has relatively good compatibility with an ultraviolet absorber has been studied (Patent Document 1).
- Surfactants having an alkylene oxide group such as ethylene oxide, propylene oxide, butylene oxide in the molecule have been widely used so far, including cosmetics and pharmaceuticals, but in recent years, their use has been considered from the viewpoint of safety and environmental impact.
- formulation studies using polyglycerin fatty acid esters, sucrose fatty acid esters and the like as surfactants that do not contain an alkylene oxide group are underway (see Patent Documents 2 to 4).
- the present invention comprises the following components (A) to (C), the surfactant HLB in the composition is less than 8, and the content ratio of the component (A) to the total amount of oily components is 100 parts by mass.
- the oil-in-water emulsified composition is 75 parts by mass or more.
- the oil-in-water emulsified composition of the present invention can be used for cosmetics, pharmaceuticals, etc. with excellent usability (good elongation, refreshing feeling), especially sunscreen, makeup base, foundation, lip balm, etc. It can be suitably applied as a skin external composition for stopping.
- an object of the present invention is to provide an oil-in-water emulsion composition that uses mannosyl erythritol lipid in an oil-in-water emulsion composition containing an ultraviolet absorber and has a good and stable feel during coating. .
- a water-in-oil emulsion composition is used.
- a mannosyl erythritol lipid, a fatty acid sorbitan ester having an HLB of 6 or less, and a UV absorber of a methoxycinnamic acid derivative and / or a benzoic acid derivative are used in combination, and a mixed HLB of surfactants in the composition is formed.
- the present invention was completed by finding that a stable oil-in-water emulsion composition can be obtained by setting the ratio to less than 8, and that the oil-in-water emulsion composition having a good feel during coating and excellent stability can be obtained. It came to do.
- methoxycinnamic acid derivatives and / or (ii) dimethylbenzoic acid derivatives are used.
- methoxycinnamic acid derivatives include ethyl paramethoxycinnamate, isopropyl paramethoxycinnamate, 2-ethoxyethyl paramethoxycinnamate, 2-ethylhexyl paramethoxycinnamate, sodium paramethoxycinnamate, potassium paramethoxycinnamate, and mono-diparamethoxycinnamic acid. Examples thereof include glyceryl 2-ethylhexanoate.
- dimethylbenzoic acid derivatives examples include paraaminobenzoic acid, ethyl paraaminobenzoate, glyceryl paraaminobenzoate, octyl paraaminobenzoate, amyl paradimethylaminobenzoate, 2-ethylhexyl paradimethylaminobenzoate, 4- [N, And N-di (2-hydroxypropyl) amino] ethyl benzoate. These can be used alone or in combination of two or more.
- UV absorbers 2-ethylhexyl paramethoxycinnamate and 2-ethylhexyl paradimethylaminobenzoate, which have good solubility in aqueous components, can be preferably mentioned, and 2-ethylhexyl paramethoxycinnamate with low odor is preferred. More preferred.
- methoxycinnamic acid derivatives are known substances.
- ubinal MC80 manufactured by BASF
- parasol MCX manufactured by DSM Nutrition
- 2-ethylhexyl paramethoxycinnamate As glyceryl di-2-methoxycinnamate mono-2-ethylhexanoate, Nomucoat X (Nisshin Oilio Co., Ltd.) can be used.
- 2-ethylhexyl paradimethylaminobenzoate Escalol 507 (ISP Japan Co., Ltd.) can be used. it can.
- the content of the component (A) in the oil-in-water emulsion composition of the present invention is preferably 1 to 40% by mass, more preferably 2 to 40% from the viewpoint of obtaining a stable oil-in-water emulsion system and oily feeling. It is 35% by mass, more preferably 3 to 25% by mass.
- the content ratio of component (A) in the oil-in-water emulsion composition of the present invention to 100 parts by mass of the total amount of oily components is 75 for obtaining a stable oil-in-water emulsion system and obtaining an excellent feel during coating.
- the amount is preferably at least part by mass, more preferably 80 to 100 parts by mass, and particularly preferably 85 to 100 parts by mass.
- oily components other than the ultraviolet absorber that can be contained in the oily component of the oil-in-water emulsified cosmetic of the present invention include squalanes such as olive squalane, rice squalane and shark squalane; dimethylpolysiloxane, cyclic silicone and the like Silicone oils; hydrocarbons such as paraffin, liquid paraffin, petrolatum, olefin oligomer, squalane; vegetable oils such as jojoba oil, olive oil, macadamia nut oil; triglycerides such as glyceryl tri-2-ethylhexanoate and glyceryl triisostearate; beeswax, mole Waxes such as carnauba wax; ester oils such as octyldodecyl myristate, cetyl palmitate, isostearyl isostearate, isopropyl myristate; cetanol, behenyl alcohol, iso
- the content of the oil component (including component (A)) in the oil-in-water emulsified cosmetic of the present invention is preferably 1 to 40% by mass from the viewpoint of weight during application and oily feeling, and 2 to 35% by mass. % Is more preferable, and 3 to 30% by mass is further preferable.
- a stable oil-in-water emulsion composition can be obtained by using (B) HLB6 or lower fatty acid sorbitan ester in addition to (C) mannosyl erythritol lipid, which is a kind of biosurfactant. .
- the HLB value is an index representing the ratio of the relative affinity of a surfactant to both liquids in an oil-water system.
- those having a small HLB value (particularly about HLB 3 to 6) have a high affinity for oil and are lipophilic. And tends to produce a water-in-oil emulsion composition.
- Those having a high HLB value (particularly about HLB 8 to 18) are highly hydrophilic and tend to produce an oil-in-water emulsion composition.
- the fatty acid sorbitan ester having an HLB of 6 or less used in the oil-in-water emulsion composition of the present invention is generally used as an emulsifier in a water-in-oil emulsion composition because of its low HLB value.
- HLB hydrophilic-lipophilic balance ⁇ Hydrophilic-Lypophilic Balance>
- Griffin (Griffin) equation.
- fatty acid sorbitan esters those having an HLB of 1 to 6 are preferred, more preferably an HLB of 3 to 5.5, and a carbon number of 10 from the viewpoint of obtaining a stable oil-in-water emulsion system with mannosyl erythritol lipid.
- the content of the component (B) in the oil-in-water emulsion composition of the present invention is preferably 0.01 to 20% by mass from the viewpoint of obtaining a stable oil-in-water emulsion system and irritation. It is more preferably ⁇ 12% by mass, and further preferably 1 ⁇ 8% by mass.
- the oil-in-water emulsion composition of the present invention can provide a stable oil-in-water emulsion system without containing a surfactant having a polyalkylene oxide group, the polyalkylene oxide group is safe and environmentally friendly. It is desirable that the surfactant having the In addition, a stable oil-in-water emulsion system can be obtained even if it does not contain a surfactant having a high hydrophilicity, particularly HLB 8 or higher, and therefore it is substantially free of a surfactant having an HLB of 8 or higher. May be.
- substantially not contained means that the component may be contained in an amount of 1% by mass or less, preferably 0.5% by mass or less, more preferably 0.01% or less, based on the total amount of the composition. It shows that.
- Mannosyl erythritol lipid (hereinafter, also referred to as MEL) used in the present invention is a natural surfactant produced by yeast. Erythritol is substituted at the 1-position of mannose and at the 2- and 3-positions. It is a compound having a structure in which an acyl group is substituted and an acetyl group may be substituted at the 4-position and the 6-position.
- MEL-A MEL-A
- MEL-B MEL-B
- MEL-C MEL-D
- MEL-D MEL-D
- R 1 and R 2 represent a hydrocarbon group. That is, MEL-A is a compound having an acyl group having 5 to 19 carbon atoms at the 2nd and 3rd positions of mannose and the acetyl group at the 4th and 6th positions of mannose in the formula (I).
- MEL-B mannose 4-position acetyl group (CH 3 CO) in formula (I) is H
- MEL-C mannose 6-position acetyl group (CH 3 CO) in formula (I).
- H and MEL-D is H in the acetyl group (CH 3 CO) at the 4-position and 6-position of mannose in formula (I).
- R 1 and R 2 are the same or different and each represents a hydrogen atom or a linear or branched alkyl group having 1 to 18 carbon atoms, or an alkenyl group or alkadienyl having a straight chain or branched chain having 2 to 18 carbon atoms. Group or alkatrienyl group. n represents an integer of 6 to 10, and m represents an integer of 6 to 10, respectively. ]
- MEL has an acyl group having a saturated or unsaturated linear or branched group having 1 to 19 carbon atoms at the 2nd and 3rd positions of mannose, and the 4th, 6th and 6th positions of mannose. It is a compound in which the position is an acetyl group (either one of acetyl groups at the 4th and 6th positions of mannose, or both may be a hydroxyl group).
- the total number of carbon atoms of the 2-position and 3-position acyl groups is preferably 10 to 38, more preferably 14 to 30.
- R 1 and R 2 include C 7 -C 11 alkyl groups such as CH 3 (CH 2 ) 6 , CH 3 (CH 2 ) 8 , CH 3 (CH 2 ) 10 ; C 7 H 14 , alkadienyl groups of C 7 H 12, C 9 H 16, C 11 C 7 ⁇ C 11 , such as H 20;; C 7 H 10 , C 9 H 18, C 11 alkenyl group having C 7 ⁇ C 11, such as H 22 C 7 -C 11 alkatrienyl groups such as C 9 H 14 , C 11 H 18 and the like can be mentioned.
- MELs commercially available products can be used.
- the content of component (C) in the oil-in-water emulsion composition of the present invention is preferably 0.005 to 8% by mass, more preferably 0.01 to 5% by mass, and particularly preferably 0.05 to 1% by mass. . Since mannosyl erythritol lipid is produced by fermenting vegetable oil, plant protein, etc., it is not only expensive, but may produce a raw material odor. Within this range, a stable oil-in-water emulsification system is obtained, the usability is good, and the raw material odor is slight, which is preferable.
- the mixed HLB of the surfactant in the oil-in-water emulsion composition of the present invention is less than 8.
- a stable oil-in-water emulsion composition can be obtained despite the incorporation of a sufficient amount of the ultraviolet absorber.
- the surfactant mixed HLB is preferably less than 8, more preferably 4 to 7.5, and even more preferably 4.5 to 7.
- the HLB of the mixed surfactant composed of two or more surfactants can be obtained as follows.
- the HLB of the mixed surfactant is obtained by averaging the HLB values of the respective surfactants based on the blending ratio.
- HLBx indicates the HLB value of surfactant X.
- Wx indicates the weight (g) of the surfactant X having a value of HLBx.
- oil-in-water emulsion composition of the present invention in addition to the above components, water; coloring pigments such as tar dyes and iron oxides; preservatives such as paraben and phenoxyethanol; sodium cetyl sulfate, N-stearoyl-L-glutamic acid
- Anionic surfactants such as salts; Nonionic surfactants such as polyhydric alcohol fatty acid esters, polyglycerin fatty acid esters, modified silicones, and sucrose esters; Cationic surfactants such as tetraalkylammonium salts; Betaine type, sulfobetaine Type, sulfoamino acid type amphoteric surfactants; natural surfactants such as lecithin, lysophosphatidylcholine, ceramide, cerebroside; pigments such as titanium oxide and zinc oxide; antioxidants such as dibutylhydroxytoluene; Sodium, magnesium chloride, sodium sulfate, nitric acid
- an extract of a plant, seaweed or fungus body can be used.
- the oil-in-water emulsified composition of the present invention has a feeling when applied to the skin, for example, good elongation and a feeling such as a refreshing feeling. Therefore, the oil-in-water emulsion composition of the present invention can be used for cosmetics, pharmaceuticals, and the like, particularly sunscreens (emulsion type, cream type, beauty liquid type, etc.), makeup bases, foundations, lip balms, etc. It can be suitably applied as a skin external composition for sunscreen.
- the fatty acid sorbitan ester of component (B) is selected from the group consisting of sorbitan monostearate, sorbitan monoisostearate, sorbitan sesquiisostearate, sorbitan sesquioleate, sorbitan monooleate, sorbitan trioleate, and sorbitan monolaurate
- Tables 1 and 2 show the sensory test results immediately after the production of the examples and comparative examples. Further, the appearance of the sample was observed by a microscopic method to determine the emulsion type. As shown in Tables 1 and 2, the examples of the present invention formed an oil-in-water sunscreen composition, and exhibited excellent usability such as good elongation and lack of oiliness. On the other hand, the comparative example did not form an oil-in-water emulsion composition and the touch was not satisfactory. In Comparative Examples 1 and 2, since the preparations were separated, the sensory test could not be performed.
- Example 12 Sunscreen milk was prepared with the composition described in Table 3, and the sensory test was conducted.
- Table 3 shows the results of testing the various characteristics of each test example. As shown in Table 3, the examples of the present invention showed excellent usability.
- Example 13 (sunscreen cream) A sunscreen cream was prepared with the composition described in Table 4, and the sensory test was conducted.
- Example 14 (Sunscreen moisturizing serum) A sunscreen serum was prepared with the composition shown in Table 5, and the sensory test was conducted.
- Table 5 shows the results of testing the various characteristics of each test example. As shown in Table 5, the examples of the present invention showed excellent usability.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
(A)下記(i)及び/又は(ii)の紫外線吸収剤
(i)パラメトキシ桂皮酸エチル、パラメトキシ桂皮酸イソプロピル、パラメトキシ桂皮酸2-エトキシエチル、パラメトキシ桂皮酸2-エチルヘキシル、パラメトキシ桂皮酸ナトリウム、パラメトキシ桂皮酸カリウム及びジパラメトキシ桂皮酸モノ-2-エチルヘキサン酸グリセリルからなる群から選択される1種又は2種以上のメトキシ桂皮酸誘導体
(ii)パラアミノ安息香酸、パラアミノ安息香酸エチル、パラアミノ安息香酸グリセリル、パラアミノ安息香酸オクチル、パラジメチルアミノ安息香酸アミル、パラジメチルアミノ安息香酸2-エチルヘキシル及び4-[N,N-ジ(2-ヒドロキシプロピル)アミノ]安息香酸エチルからなる群から選択される1種又は2種以上の安息香酸誘導体
(B)HLBが6以下の脂肪酸ソルビタンエステル、
(C)マンノシルエリスリトールリピッド。
従って、本発明の課題は、紫外線吸収剤を配合した水中油型乳化組成物において、マンノシルエリスリトールリピッドを用い、塗布時の感触が良好でかつ安定な水中油型乳化組成物を提供することにある。
本発明の水中油型乳化化粧料中の油性成分(成分(A)を含む)の含有量は、塗布中の重さ、油性感の点から、1~40質量%が好ましく、2~35質量%がより好ましく、3~30質量%がさらに好ましい。
ここで、HLB(親水性-親油性のバランス<Hydrophilic-Lypophilic Balance>)は、界面活性剤の全分子量に占める親水基部分の分子量を示すものであり、非イオン界面活性剤については、グリフィン(Griffin)の式により求められるものである。
R1、R2の好ましい基としては、CH3(CH2)6、CH3(CH2)8、CH3(CH2)10などのC7~C11のアルキル基;C7H14、C9H18、C11H22などのC7~C11のアルケニル基;C7H12、C9H16、C11H20などのC7~C11のアルカジエニル基;C7H10、C9H14、C11H18などのC7~C11のアルカトリエニル基が挙げられる。
また、混合HLBが高い場合には、水中油型でなく油中水型乳化組成物となってしまい、油性感が強くなってしまう。
このような界面活性剤の混合HLBとしては、8未満が好ましく、4~7.5がより好ましく、4.5~7がさらに好ましい。
Wxは、HLBxの値を有する界面活性剤Xの重量(g)を示す。
[1]次の成分(A)~(C)を含有し、組成物中の界面活性剤の混合HLBが8未満であり、成分(A)の油性成分の総量100質量部に対する含有比率が75質量部以上であることを特徴とする水中油型乳化組成物。
(A)下記(i)及び/又は(ii)の紫外線吸収剤
(i)パラメトキシ桂皮酸エチル、パラメトキシ桂皮酸イソプロピル、パラメトキシ桂皮酸2-エトキシエチル、パラメトキシ桂皮酸2-エチルヘキシル、パラメトキシ桂皮酸ナトリウム、パラメトキシ桂皮酸カリウム及びジパラメトキシ桂皮酸モノ-2-エチルヘキサン酸グリセリルからなる群から選択される1種又は2種以上のメトキシ桂皮酸誘導体
(ii)パラアミノ安息香酸、パラアミノ安息香酸エチル、パラアミノ安息香酸グリセリル、パラアミノ安息香酸オクチル、パラジメチルアミノ安息香酸アミル、パラジメチルアミノ安息香酸2-エチルヘキシル及び4-[N,N-ジ(2-ヒドロキシプロピル)アミノ]安息香酸エチルからなる群から選択される1種又は2種以上の安息香酸誘導体
(B)HLBが6以下の脂肪酸ソルビタンエステル、
(C)マンノシルエリスリトールリピッド。
[2]成分(A)が、パラメトキシ桂皮酸2-エチルヘキシル及び/又はパラジメチルアミノ安息香酸2-エチルヘキシルである[1]記載の水中油型乳化組成物。
[3]成分(B)の脂肪酸ソルビタンエステルが、モノステアリン酸ソルビタン、モノイソステアリン酸ソルビタン、セスキイソステアリン酸ソルビタン、セスキオレイン酸ソルビタン、モノオレイン酸ソルビタン、トリオレイン酸ソルビタン及びモノラウリン酸ソルビタンからなる群から選択される1種又は2種以上である[1]又は[2]に記載の水中油型乳化組成物。
[4]成分(B)が、HLBが1~6の脂肪酸ソルビタンエステルである[1]~[3]のいずれかに記載の水中油型乳化組成物。
[5]組成物中の界面活性剤の混合HLBが4~7.5である[1]~[4]のいずれかに記載の水中油型乳化組成物。
[6]組成物中の界面活性剤の混合HLBが4.5~7である[1]~[5]のいずれかに記載の水中油型乳化組成物。
[7]成分(B)が、HLBが3~5.5で、炭素数10~20の分岐脂肪酸基を有する脂肪酸ソルビタンエステルである[1]~[6]のいずれかに記載の水中油型乳化組成物。
[8]成分(A)が、パラメトキシ桂皮酸2-エチルヘキシルである[1]~[7]のいずれかに記載の水中油型乳化組成物。
[9]ポリアルキレンオキサイド基を有する界面活性剤を実質的に含まないものである[1]~[8]のいずれかに記載の水中油型乳化組成物。
[10]HLB8以上の界面活性剤を実質的に含まないものである[1]~[9]のいずれかに記載の水中油型乳化組成物。
[11]成分(A)の含有量が、1~40質量%である[1]~[10]のいずれかに記載の水中油型乳化組成物。
[12]成分(A)の含有量が2~35質量%である[1]~[11]のいずれかに記載の水中油型乳化組成物。
[13]成分(A)の含有量が3~25質量%である[1]~[12]のいずれかに記載の水中油型乳化組成物。
[14]油性成分(成分(A)を含む)の含有量が1~40質量%である[1]~[13]のいずれかに記載の水中油型乳化組成物。
[15]油性成分(成分(A)を含む)の含有量が2~35質量%である[1]~[14]のいずれかに記載の水中油型乳化組成物。
[16]油性成分(成分(A)を含む)の含有量が3~30質量%である[1]~[15]のいずれかに記載の水中油型乳化組成物。
[17]成分(B)の含有量が0.01~20質量%である[1]~[16]のいずれかに記載の水中油型乳化組成物。
[18]成分(B)の含有量が0.1~12質量%である[1]~[17]のいずれかに記載の水中油型乳化組成物。
[19]成分(C)の含有量が、0.005~8質量%である[1]~[18]のいずれかに記載の水中油型乳化組成物。
[20]成分(C)の含有量が、0.01~5質量%である[1]~[19]のいずれかに記載の水中油型乳化組成物。
[21]成分(C)の含有量が0.02~1質量%である[1]~[20]のいずれかに記載の水中油型乳化組成物。
[22]皮膚用化粧料である[1]~[21]のいずれかに記載の水中油型乳化組成物。
成人女性20名の評価パネラーに試料を使用してもらい、使用後に塗布中の重さ(伸びの良さ)、塗布後の油性感のなさ(さっぱり感)に関し、感触が良いと答えた人数で評価した。また、実施例1~10、比較例1~8については、原料臭の有無に関し、原料臭を特に感じないと答えた人数で評価した。
表1及び2に記載の組成でサンスクリーンを調製し、前記の官能試験を実施した。
各成分を室温にて均一に混合攪拌する。
実施例及び比較例の製造直後の官能試験結果を表1及び2に示す。
表3に記載の組成でサンスクリーンミルクを調製し、前記の官能試験を実施した。
各成分を室温にて均一に混合攪拌する。
各試験例の前記諸特性を試験した結果を表3に示す。表3に示すように、本発明の実施例は優れた使用感を示した。
表4に記載の組成でサンスクリーンクリームを調製し、前記の官能試験を実施した。
各成分を室温にて均一に混合攪拌する。
各試験例の前記諸特性を試験した結果を表4に示す。表4に示すように、本発明の実施例は優れた使用感を示した。
表5に記載の組成でサンスクリーン美容液を調製し、前記の官能試験を実施した。
各成分を室温にて均一に混合攪拌する。
各試験例の前記諸特性を試験した結果を表5に示す。表5に示すように、本発明の実施例は優れた使用感を示した。
Claims (10)
- 次の成分(A)~(C)を含有し、組成物中の界面活性剤の混合HLBが8未満であり、成分(A)の油性成分の総量100質量部に対する含有比率が75質量部以上であることを特徴とする水中油型乳化組成物。
(A)下記(i)及び/又は(ii)の紫外線吸収剤
(i)パラメトキシ桂皮酸エチル、パラメトキシ桂皮酸イソプロピル、パラメトキシ桂皮酸2-エトキシエチル、パラメトキシ桂皮酸2-エチルヘキシル、パラメトキシ桂皮酸ナトリウム、パラメトキシ桂皮酸カリウム及びジパラメトキシ桂皮酸モノ-2-エチルヘキサン酸グリセリルからなる群から選択される1種又は2種以上のメトキシ桂皮酸誘導体
(ii)パラアミノ安息香酸、パラアミノ安息香酸エチル、パラアミノ安息香酸グリセリル、パラアミノ安息香酸オクチル、パラジメチルアミノ安息香酸アミル、パラジメチルアミノ安息香酸2-エチルヘキシル及び4-[N,N-ジ(2-ヒドロキシプロピル)アミノ]安息香酸エチルからなる群から選択される1種又は2種以上の安息香酸誘導体
(B)HLBが6以下の脂肪酸ソルビタンエステル、
(C)マンノシルエリスリトールリピッド。 - 成分(A)が、パラメトキシ桂皮酸2-エチルヘキシル及び/又はパラジメチルアミノ安息香酸2-エチルヘキシルである請求項1記載の水中油型乳化組成物。
- 成分(B)の脂肪酸ソルビタンエステルが、モノステアリン酸ソルビタン、モノイソステアリン酸ソルビタン、セスキイソステアリン酸ソルビタン、セスキオレイン酸ソルビタン、モノオレイン酸ソルビタン、トリオレイン酸ソルビタン及びモノラウリン酸ソルビタンからなる群から選択される1種又は2種以上である請求項1又は2に記載の水中油型乳化組成物。
- 成分(B)が、HLBが1~6の脂肪酸ソルビタンエステルである請求項1~3のいずれかに記載の水中油型乳化組成物。
- 成分(A)の含有量が、1~40質量%である請求項1~4のいずれかに記載の水中油型乳化組成物。
- 油性成分(成分(A)を含む)の含有量が、1~40質量%である請求項1~5のいずれかに記載の水中油型乳化組成物。
- 成分(B)の含有量が、0.01~20質量%である請求項1~6のいずれかに記載の水中油型乳化組成物。
- 成分(C)の含有量が、0.005~8質量%である請求項1~7のいずれかに記載の水中油型乳化組成物。
- 成分(C)の含有量が、0.02~1質量%である請求項1~8のいずれかに記載の水中油型乳化組成物。
- 組成物中の界面活性剤の混合HLBが4~7.5である請求項1~9のいずれかに記載の水中油型乳化組成物。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11854607.6A EP2662068B1 (en) | 2011-01-06 | 2011-11-24 | Oil-in-water emulsion composition |
JP2012551797A JP5927125B2 (ja) | 2011-01-06 | 2011-11-24 | 水中油型乳化組成物 |
CN201180064491.0A CN103298443B (zh) | 2011-01-06 | 2011-11-24 | 水包油型乳化组合物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011001094 | 2011-01-06 | ||
JP2011-001094 | 2011-01-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2012093524A1 true WO2012093524A1 (ja) | 2012-07-12 |
Family
ID=46457387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2011/076994 WO2012093524A1 (ja) | 2011-01-06 | 2011-11-24 | 水中油型乳化組成物 |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2662068B1 (ja) |
JP (1) | JP5927125B2 (ja) |
CN (1) | CN103298443B (ja) |
WO (1) | WO2012093524A1 (ja) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210032423A (ko) * | 2018-07-11 | 2021-03-24 | 아쿠아노바 아게 | 커큐민 및 추가 활성 물질로서 적어도 1종의 칸나비노이드를 포함하는 가용화물 |
CN113827523A (zh) * | 2021-10-26 | 2021-12-24 | 中国农业科学院麻类研究所 | 一种玫瑰组合物及其应用 |
CN114288194A (zh) * | 2021-12-30 | 2022-04-08 | 彭氏(惠州)实业发展有限公司 | 一种不含去离子水的双层护肤精华液及其制备方法 |
US11786484B2 (en) | 2018-07-11 | 2023-10-17 | Aquanova Ag | Xanthohumol solubilizate |
US11931322B2 (en) | 2017-07-11 | 2024-03-19 | Aquanova Ag | Solubilizate with curcumin and optionally at least one other active substance |
WO2024142920A1 (ja) * | 2022-12-26 | 2024-07-04 | 株式会社 資生堂 | 水中油型乳化化粧料 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106727027B (zh) * | 2017-01-18 | 2020-07-07 | 韩后化妆品股份有限公司 | 抗蓝光、抗氧化、清除自由基组合物、护肤品及制备方法 |
CN111870543A (zh) * | 2020-08-24 | 2020-11-03 | 汕头市奇伟实业有限公司 | 一种抗氧化番茄红素微乳液及其制备方法 |
EP4046620A1 (en) * | 2021-02-23 | 2022-08-24 | Beiersdorf AG | Emulsions comprising mannosylerythritol lipid (mel) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007122822A2 (ja) * | 2007-07-27 | 2007-11-01 | Shiseido Company, Ltd. | 水中油型乳化日焼け止め化粧料 |
JP2009167159A (ja) * | 2007-12-21 | 2009-07-30 | Toyobo Co Ltd | バイオサーファクタントを含有する化粧品組成物 |
JP2009275017A (ja) * | 2008-05-16 | 2009-11-26 | Toyobo Co Ltd | バイオサーファクタント含有水中油型乳化化粧品組成物 |
JP2011168548A (ja) * | 2010-02-19 | 2011-09-01 | Toyobo Co Ltd | 水中油型乳化化粧料 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8246263B2 (en) * | 2007-07-20 | 2012-08-21 | Diversey, Inc. | Floor finish applicator |
JP2009149567A (ja) * | 2007-12-21 | 2009-07-09 | Toyobo Co Ltd | バイオサーファクタントを含有する化粧品組成物 |
JP2009149566A (ja) * | 2007-12-21 | 2009-07-09 | Toyobo Co Ltd | バイオサーファクタントを含有する化粧品組成物 |
JP2009167158A (ja) * | 2007-12-21 | 2009-07-30 | Toyobo Co Ltd | バイオサーファクタントを含有する化粧品組成物 |
-
2011
- 2011-11-24 CN CN201180064491.0A patent/CN103298443B/zh not_active Expired - Fee Related
- 2011-11-24 JP JP2012551797A patent/JP5927125B2/ja not_active Expired - Fee Related
- 2011-11-24 EP EP11854607.6A patent/EP2662068B1/en not_active Not-in-force
- 2011-11-24 WO PCT/JP2011/076994 patent/WO2012093524A1/ja active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007122822A2 (ja) * | 2007-07-27 | 2007-11-01 | Shiseido Company, Ltd. | 水中油型乳化日焼け止め化粧料 |
JP2009167159A (ja) * | 2007-12-21 | 2009-07-30 | Toyobo Co Ltd | バイオサーファクタントを含有する化粧品組成物 |
JP2009275017A (ja) * | 2008-05-16 | 2009-11-26 | Toyobo Co Ltd | バイオサーファクタント含有水中油型乳化化粧品組成物 |
JP2011168548A (ja) * | 2010-02-19 | 2011-09-01 | Toyobo Co Ltd | 水中油型乳化化粧料 |
Non-Patent Citations (1)
Title |
---|
TOKUMA FUKUOKA: "Expansion of structures and functions of novel glycolipid biosurfactants", OLEOSCIENCE, vol. 9, no. 4, 1 April 2009 (2009-04-01), pages 127 - 133, XP055118251 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11931322B2 (en) | 2017-07-11 | 2024-03-19 | Aquanova Ag | Solubilizate with curcumin and optionally at least one other active substance |
KR20210032423A (ko) * | 2018-07-11 | 2021-03-24 | 아쿠아노바 아게 | 커큐민 및 추가 활성 물질로서 적어도 1종의 칸나비노이드를 포함하는 가용화물 |
JP2021524488A (ja) * | 2018-07-11 | 2021-09-13 | アクアノヴァ アクチエンゲゼルシャフト | クルクミンと、更なる活性剤としての少なくともカンナビノイドthcとを含む可溶化物 |
US11786484B2 (en) | 2018-07-11 | 2023-10-17 | Aquanova Ag | Xanthohumol solubilizate |
KR102659259B1 (ko) | 2018-07-11 | 2024-04-23 | 아쿠아노바 아게 | 커큐민 및 추가 활성 물질로서 적어도 1종의 칸나비노이드를 포함하는 가용화물 |
JP7545952B2 (ja) | 2018-07-11 | 2024-09-05 | アクアノヴァ アクチエンゲゼルシャフト | クルクミンと、更なる活性剤としての少なくともカンナビノイドthcとを含む可溶化物 |
CN113827523A (zh) * | 2021-10-26 | 2021-12-24 | 中国农业科学院麻类研究所 | 一种玫瑰组合物及其应用 |
CN113827523B (zh) * | 2021-10-26 | 2023-10-17 | 中国农业科学院麻类研究所 | 一种玫瑰组合物及其应用 |
CN114288194A (zh) * | 2021-12-30 | 2022-04-08 | 彭氏(惠州)实业发展有限公司 | 一种不含去离子水的双层护肤精华液及其制备方法 |
CN114288194B (zh) * | 2021-12-30 | 2024-03-22 | 彭氏(惠州)实业发展有限公司 | 一种不含去离子水的双层护肤精华液及其制备方法 |
WO2024142920A1 (ja) * | 2022-12-26 | 2024-07-04 | 株式会社 資生堂 | 水中油型乳化化粧料 |
Also Published As
Publication number | Publication date |
---|---|
CN103298443B (zh) | 2015-06-17 |
JP5927125B2 (ja) | 2016-05-25 |
JPWO2012093524A1 (ja) | 2014-06-09 |
EP2662068A1 (en) | 2013-11-13 |
EP2662068B1 (en) | 2017-07-05 |
CN103298443A (zh) | 2013-09-11 |
EP2662068A4 (en) | 2015-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5927125B2 (ja) | 水中油型乳化組成物 | |
JP5826171B2 (ja) | 水中油型乳化組成物 | |
JP4417857B2 (ja) | 化粧料 | |
TWI395596B (zh) | 乳膠組成物 | |
JP5917043B2 (ja) | 皮膚外用剤 | |
JP5693245B2 (ja) | 皮膚外用剤 | |
JP4137047B2 (ja) | 乳化化粧料 | |
JP2016094398A (ja) | 乳化組成物 | |
JP6531514B2 (ja) | 乳化組成物 | |
JP6053359B2 (ja) | 乳化組成物及びその製造方法 | |
JP2007238488A (ja) | 乳化型皮膚外用剤 | |
JP5058457B2 (ja) | 化粧料用組成物及び化粧料 | |
KR20160056842A (ko) | 점증제 없이 점도 및 경도를 갖는 화장료 조성물 | |
JP5825934B2 (ja) | ジェル状皮膚外用剤 | |
JP2014162724A (ja) | 油中水型乳化組成物 | |
JP6101310B2 (ja) | 水中油型乳化組成物 | |
JP7165090B2 (ja) | 安定化した高内相w/o型乳化組成物及びこれを利用した化粧料 | |
JP7265860B2 (ja) | 高内相w/o型乳化組成物及びこれを利用した化粧料 | |
JP6586854B2 (ja) | 乳化組成物 | |
KR102014935B1 (ko) | 액정 타입의 택시폴린 테트라 옥타노에이트를 포함하는 화장료 조성물 | |
JP7326253B2 (ja) | 低粘度の油中水エマルションを得るための乳化コンビネーション | |
TWI398442B (zh) | Emulsified skin external preparation and the external preparation of the skin method | |
JP6106777B2 (ja) | 皮膚外用剤 | |
JP6504691B2 (ja) | 液晶乳化組成物 | |
JP2019156755A (ja) | 日焼け止め化粧料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11854607 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2012551797 Country of ref document: JP Kind code of ref document: A |
|
REEP | Request for entry into the european phase |
Ref document number: 2011854607 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011854607 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |